¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"solubility product constant"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • end product
    ÃÖÁ¾»ê¹°
  • fibrin degradation product
    ¼¶À¯¼ÒºÐÇØ»ê¹°, ÇǺ기ºÐÇØ»ê¹°
  • intermediate product
    Áß°£»ê¹°
  • leukocyte-depleted blood product
    ¹éÇ÷±¸Á¦°ÅÇ÷¾×Á¦Á¦
  • marine product
    ÇØ»ê¹°
  • product
    1. »ê¹° 2. »ý¼º¹°
  • split product
    ºÐ¸®»ê¹°
  • substitution product
    ġȯ»ý¼º¹°
  • antigen diffusion constant
    Ç׿øÈ®»ê»ó¼ö
  • association constant
    ¿¬ÇÕ»ó¼ö, °áÇÕ»ó¼ö
  • affinity constant
    ģȭ»ó¼ö
  • absolute constant
    Àý´ë»ó¼ö
  • computer-guided constant infusion
    ÄÄÇ»ÅÍÀ¯µµÇ×¼ÓÁÖÀÔ
  • constant
    »ó¼ö
  • constant bias
    »óÁ¸Ä¡¿ìħ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • degradation product
    ºÐÇØ»ê¹°
  • end product
    ÃÖÁ¾»ê¹°
  • fibrin degradation product
    ¼¶À¯¼ÒºÐÇØ»ê¹°
  • intermediate product
    Áß°£»ê¹°, Áß°£´ë»ç¹°
  • leukocyte-depleted blood product
    ¹éÇ÷±¸Á¦°ÅÇ÷¾×Á¦Á¦
  • marine product
    ÇØ»ê¹°
  • product
    »ý¼º¹°, »ê¹°
  • split product
    ºÐ¸®»ê¹°
  • substitution product
    ġȯü
  • absolute constant
    Àý´ë»ó¼ö
  • affinity constant
    ģȭ»ó¼ö
  • air kerma-rate constant
    °ø±âÄ¿¸¶À²»ó¼ö
  • antigen diffusion constant
    Ç׿øÈ®»ê»ó¼ö
  • association constant
    ¿¬ÇÕ»ó¼ö, °áÇÕ»ó¼ö
  • constant bias
    »óÁ¸ÆíÀç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • growth constant
    Áõ½Ä»ó¼ö
  • growth constant
    ¼ºÀå»ó¼ö(ÊÙË×Ëà).
  • growth rate constant
    Áõ½Ä·ü»ó¼ö
  • hemoglobin Constant Spring
    ÄÁ½ºÅÏÆ® ½ºÇÁ¸µ Ç÷»ö¼Ò
  • phase constant
    À§»ó»ó¼ö(êÈßÓßÈâ¦).
  • polarization constant
    ºÐ±Ø»ó¼ö(ÝÂпßÈâ¦).
  • quantum constant
    ¾çÀÚ»ó¼ö(åÖí­ßÈâ¦).
  • radioactive constant
    ¹æ»ç´É»ó¼ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • assimilation product
    µ¿È­»ý»ê¹°.
  • biological product
    »ý¹°ÇÐÀû Á¦Á¦(¡­ð²ð¥).
  • blood product
    Ç÷¾×Á¦Á¦.
  • by-product
    ºÎ»ê¹°.
  • decay product
    ºØ±«»ý¼º
  • degradation product
    ºÐÇØ»ê¹°(ÝÂú°ß§Úª)
  • distortion product otoacoustic emission
    º¯Á¶ÀÌÀ½Çâ¹Ý»ç
  • end product
    ÃÖÁ¾»ê¹°.»ýÈ­Á¾»ê¹°.
  • fibrin degradation product
  • intermediate product
    Áß°£»ý¼º¹°(¡­ßæà÷Úª), Áß°£»ê¹°, Áß°£´ë»ç¹°.
  • ionic product
    ÀÌ¿ÂÀû(¡­îÝ), À̿»깰.
  • metabolic product
    ´ë»ç»ê¹°(¡­ß§Úª).
  • otoacoustic emission, distortion product
    ÀÌÀ½Çâ¹æ»ç¿Ö°î¹°
  • product costing
    Á¦Ç°°¡°Ý»êÁ¤
  • product of metabolism
    ´ë»ç»ê¹°(ÓÛÞóß§Úª).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • allosteric constant
    ¾Ë·Î½ºÅ׸® »ó¼ö(ßÈâ¦)
  • association constant
    ¿¬ÇÕ»ó¼ö(æáùêßÈâ¦)
  • average intrinsic association constant
    Æò±Õ°íÀ¯¿¬ÇÕ»ó¼ö (øÁгͳêóæáùêßÈâ¦)
  • basicity constant
    ¿°±â(µµ)»ó¼ö(ç¤Ðñ(Óø)ßÈâ¦)
  • binding constant
    °áÇÕ»ó¼ö(Ì¿ùêßÈâ¦)
  • catalytic constant
    Ã˸Żó¼ö(õºØÚßÈâ¦)
  • catalytic rate constant
    Ã˸żӵµ»ó¼ö(õºØÚáÜÓøßÈâ¦)
  • concentration equilibrium constant
    "³óµµÆòÇü»ó¼ö(ÒØÓøøÁû¬ßÈâ¦), (ÔÒ) apparent equilibrium constant"
  • constant region
    ºÒº¯±¸¿ª(ÝÕܨϡæ´)
  • coupling constant
    ¦Áþ±â »ó¼ö(ßÈâ¦)
  • decay constant
    ºØ±« »ó¼ö(ÝÚÎÕßÈâ¦)
  • dielectric constant
    À¯Àü»ó¼ö(ë¯ï³ßÈâ¦)
  • diffusion constant
    "È®»ê»ó¼ö(üªß¤ßÈâ¦), (ÔÒ) diffusion coefficient"
  • disintegration constant
    "ºØ±«»ó¼ö(ÝÚÎÕßÈâ¦), (ÔÒ) decay constant"
  • dissociation constant
    ÇØ¸®»ó¼ö(ú°×îßÈâ¦)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ADP adenopathy; adenosine diphosphate; administrative psychiatry; approved drug product; area diastolic ...
AGE acrylamide gel; acute gastroenteritis; advanced glycation end product; agarose gel electrophoresis; ...
DAP data acquisition processor; depolarizing afterpotential; diabetes-associated peptide; diaminopimelic...
DP data processing; deep pulse; definitive procedure; degradation product; degree of polymerization; de...
DRP digoxin reduction product; dorsal root potential; dystrophin-related protein
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CE Constant error
CFV Constant flow ventilation
tc Time constant
CH chain constant
14C constant for
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • affinity constant
    ģȭ »ó¼ö
  • Boltzman constant
    Boltzman »ó¼ö
  • constant
    »ó¼ö, ÀÏÁ¤ÀÇ, ºÒº¯ÀÇ, »óÁ¸ÀÇ, »óÁ¸¼ºÀÇ
    ÁÙ°ð, °è¼Ó, ¹«º¯È­ ±×´ë·Î.
  • constant current
    Á¤Àü·ù
  • constant field equation
    Á¤ÀüÀå ¹æÁ¤½Ä
  • constant force
    Ç×·Â
  • constant pain
    Áö¼ÓÅë
  • constant temperature
    Ç׿Â
  • constant turn over
    ÀÏÁ¤ÇÑ È¸Àü
  • constant volume
    ÀÏÁ¤ ºÎÇÇ, Á¤Àû
  • dielectric constant
    À¯ÀüÀ², À¯Àü»ó¼ö, ÅõÀü»ó¼ö
  • dissociation constant
    ÇØ¸® Á¤¼ö
  • electrolytic dissociation constant
    Àü¸® »ó¼ö, ÀüÇØÁú ÇØ¸® »ó¼ö
  • fast time constant circuit
    °í¼Ó ½Ã°£ °íÁ¤ ȸ·Î
  • lattice constant
    °ÝÀÚ »ó¼ö
    °áÁ¤ °ÝÀÚÀÇ ¿©·¯ °¡Áö Çü¿¡ ´ëÇÏ¿© °¢°¢ÀÇ ´ÜÀ§ °ÝÀÚÀÇ Å©±â¿Í ¸ð¾çÀ» ³ªÅ¸³»±â À§ÇÏ¿© Àû¿ëÇÏ´Â Á¤¼ö.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
product-moment correlation A statistical procedure which yields the correlation coefficient referred to as r (-1.00 to +1.00) and involves the actual values, rather than the ranks (rank order) of the measurements.
(05 Mar 2000)
product packaging Form in which product is processed or wrapped and labelled.
(12 Dec 1998)
product recovery The process of separating a desired recombinant protein from the growth medium and the other elements in the host cells in which it was grown.
(14 Nov 1997)
product surveillance, postmarketing Surveillance of drugs, devices, appliances, etc., for efficacy or adverse effects, after they have been released for general sale.
(12 Dec 1998)
secondary product <plant biology> End product of plant cell metabolism, which accumulates in or is secreted from, the cell. Includes anthocyanins, alkaloids, etc. Some are of major economic importance, for example as drugs. In contrast to a primary product that is involved in the vital metabolism of the plant.
(18 Nov 1997)
spallation product An atomic species produced in the course of the spallation of any atom.
(05 Mar 2000)
substitution product A product obtained by replacing one atom or group in a molecule with another atom or group.
(05 Mar 2000)
double product The product of systolic blood pressure multiplied by the heart frequency; a measure of heart work load.
See: Robinson index.
(05 Mar 2000)
trade name product <pharmacology> Trademarked proprietary preparations containing the generic substance. Some foreign trade name products have been selectively included here due to the relative popularity of the generic medication.
(17 Mar 1998)
end product <biochemistry> The final product of after a series of reactions with enzymes in a biochemical metabolic pathway has taken place.
(09 Oct 1997)
end product inhibition <biochemistry, physiology> The process of the end product of a particular metabolic reaction inhibiting an allosteric enzyme involved in that reaction as the reaction starts again, thus breaking the reaction cycle.
(09 Oct 1997)
end product repression Catabolite repression in which the catabolite is an end product of a particular pathway.
(05 Mar 2000)
fission product An atomic species produced in the course of the fission of a larger atom such as 235U.
(05 Mar 2000)
acid dissociation constant <chemistry> This is the equilibrium constant for the breaking apart of a weak acid into its hydrogen and conjugate base in a water solution.
(09 Oct 1997)
Ambard's constant <physiology> Obsolete law's for output of urea:
1. With the urinary urea concentration constant, urea output varies directly as the square of the concentration of the blood urea.
2. With the blood urea concentration constant, urea output varies inversely as the square root of its urinary concentration.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • national product
    (°æ)(¿¬°£)±¹¹Î»ý»ê(cf.GNP)
  • net domestic product
    ±¹³» ¼ø»ý»ê
  • net national product
    ±¹¹Î¼ø»ý»ê
  • new product
    ½ÅÁ¦Ç°(»õ·Î¿î°ÍÀ¸·Î ÀÎÁ¤µÈ Á¦Ç° ¶Ç´Â ¼­ºñ½º)
  • parity product
    ÆÐ¸®Æ¼ Á¦Ç°
  • partial product
    ºÎºÐÀû
  • product
    »ý»êǰ;Á¦ÀÛ¹°;°á°ú;¼º°ú;°ö;Àû
  • product concept
    Á¦Ç° °³³ä(²÷ÀÓ¾øÀÌ Á¦Ç°ÀÇ °³¼±À» ²ÒÇÏ´Â °æ¿µ Áöħ)
  • product liability
    (ºÒ·® »óǰ¿¡ ´ëÇØ ¼ÒºñÀÚ¿¡°Ô Áö´Â) »ý»ê¹°(ÀÚ) Ã¥ÀÓ
  • product life cycle
    Á¦Ç°ÀÇ ¶óÀÌÇÁ »çÀÌŬ
  • product line
    (¸¶ÄÉÆÃ)Á¦Ç° ¶óÀÎ(°°Àº ±â´ÉÀ» °¡Áø ¼­·Î °ü·Ã ±íÀº Á¦Ç°±º)
  • product mix
    (¸¶ÄÉÆÃ)Á¦Ç° ¹Í½º(ÆÇ¸ÅµÇ´Â ÀüÁ¦Ç°ÀÇ ¸®½ºÆ®,Æø°ú ±íÀÌÀÇ µÎÂ÷¿ø)
  • residual product
    ÀÜ¿© »ý»ê¹°;ºÎ»ê¹°
  • staple product
    ÁÖ¿ä »ê¹°
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á